Migraine Patients Respond to ICER Evidence Report on Acute Treatments for Migraine Attacks Controversial health economics group evaluating cost-effectiveness of new, groundbreaking acute therapies for migraine attacks WASHINGTON – Today, the nonprofits Headache & Migraine Policy Forum and Coalition For Headache And Migraine Patients commented…
by Danielle Kunkle, Guest Writer A migraine is one of five types of headache disorders. There are several types of migraines, including common migraine, complicated migraine, and chronic migraine. According to the Migraine Research Foundation, females experience migraine attacks more than males. In fact, out…
Do you avoid taking medications until your migraine is severe because you are afraid of rebound or medication overuse headache? Do you know which medicines put you most at risk for rebound headache? Dr. Lindsay Weitzel and Dr. Vincent Martin discuss Rebound Headache in Episode…
As part of its 2018 funding cycle, the National Headache Foundation has awarded a $100,000 grant to fund a nationwide study conducted by Dr. Erin Buchanan of Harrisburg University of Science and Technology and Clinvest Research. The goal of the project will be to improve…
The National Headache Foundation applauds the approval and release of Teva Pharmaceutical’s migraine preventive medication, Ajovy (fremenazumab), on Friday, September 14, 2018. This medication is the second in a new class of migraine preventers called CGRP monoclonal antibodies to be approved in 2018, with another…
June 28 is recognized as Headache Disease Research Day, and in 2018 headache and migraine patients have more to be excited about than ever. After decades of advocacy, education and research, the number and quality of new treatments and prevention methods available and currently in-research…
Cold and flu season has returned like clockwork. As you hit the over-the-counter aisle, rummage through your medicine cabinet at home, and prepare to combat your family’s runny noses and sore throats, remember to double check medicine labels so you don’t accidentally double up on…
Subscribe to our Newsletter
Gain access to the most current migraine and headache information, prevention,
treatment, research, and news.
